VX20-445-119

Details

Trial status
Project in Setup Participating Centres
Phase
Phase IIIb

Full title

A Phase 3b Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects Ages 6 Years
and Older Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Subjects 6 Years and Older and F/MF genotypes. Kaftrio
Trial Reference Number
134588
Recruitment target
0
Last edited date
10/07/2020

Who can take part?

Top inclusion criteria
  • Test
Top exclusion criteria
  • test

Your donation will make a difference:

Select amount